Cancer

Insilico Medicine has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ISM6331, an...

Hospitals are not only places where childhood cancer is treated—they also generate records of earlier health encounters. A new population-based...

A new analysis published in British Journal of Cancer maps how oncology drug development in the UK has evolved over...

Stem cells in the Drosophila intestine continuously generate new cells, but their division must be precisely limited to preserve tissue...

Gastrointestinal cancers still claim a disproportionate share of global cancer burden—about one fifth of all cases and roughly one third...

Insilico Medicine has announced that first-in-human Phase 1 data for ISM6331, an AI-designed pan-TEAD inhibitor, has been accepted for a...

A new AI system from La Trobe University could help clinicians forecast relapse risk in patients with stage-two bowel cancer—potentially...

A new study is turning the microscopic “how it grows” question in colorectal cancer liver metastases into a measurable molecular...

The DNA damage response (DDR) and the immune system may look like separate defense networks, but new research underscores how...

Circular RNAs (circRNAs) are gaining momentum as viral-worthy candidates in the liquid biopsy revolution. Unlike linear RNAs, circRNAs form covalently...